— Know what they know.
Not Investment Advice

MGX NASDAQ

Metagenomi, Inc. Common Stock
1W: -11.3% 1M: -12.1% 3M: -18.4% YTD: -38.9% 1Y: -57.3%
$1.02
-0.09 (-7.69%)
 
Weekly Expected Move ±6.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $38.4M mcap · 25M float · 0.632% daily turnover · Short 43% of daily vol

Balance Sheet Trends

Total Assets
$221M -31.9% ▼
4Y CAGR: +11.7%
Total Liabilities
$63M -30.3% ▼
4Y CAGR: -22.6%
Shareholders Equity
$159M -32.5% ▼
Cash & Investments
$161M -35.2% ▼
4Y CAGR: +10.4%
Total Debt
$41M -11.2% ▼
4Y CAGR: -4.5%
Net Debt
-$1M -105.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$39M$184M$141M$27M$42M
Short-Term Investments$69M$178M$131M$221M$119M
Cash & ST Investments$108M$362M$271M$248M$161M
Net Receivables$490K$1M$2M$1M$305K
Inventory$0$0$0$0$0
Other Current Assets$272K$3M$5M$8M$4M
Total Current Assets$109M$367M$278M$258M$166M
Property, Plant & Equip.$22M$33M$65M$58M$47M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$6M$8M$16M$3M$2M
Other Non-Current Assets$5M$7M$5M$6M$6M
Total Non-Current Assets$33M$48M$87M$67M$56M
Total Assets$142M$414M$365M$325M$221M
— Liabilities —
Accounts Payable$1M$2M$2M$533K$1M
Short-Term Debt$0$0$3M$0$6M
Deferred Revenue$16M$34M$49M$23M$9M
Other Current Liabilities$6M$6M$4M$5M$7M
Total Current Liabilities$25M$49M$69M$37M$23M
Long-Term Debt$30M$0$0$0$0
Other Non-Current Liab.$77M$347M$5M$2M$2M
Total Non-Current Liabilities$149M$440M$81M$52M$40M
Total Liabilities$175M$489M$150M$90M$63M
— Equity —
Common Stock$573K$3M$26K$4K$4K
Retained Earnings-$33M-$77M-$145M-$223M-$311M
Accumulated OCI-$21K-$274K$9M$709K$260K
Total Stockholders Equity-$33M-$74M$215M$235M$159M
Total Liabilities & Equity$142M$414M$365M$325M$221M
— Key Metrics —
Total Debt$49M$19M$48M$46M$41M
Net Debt$10M-$166M-$92M$18M-$1M
Total Investments$75M$185M$147M$224M$121M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms